Cambridge Investment Research Advisors’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,496
| Closed | -$234K | – | 3593 |
|
|
2024
Q3 | $234K | Sell |
3,496
-23
| -0.7% | -$1.54K | ﹤0.01% | 3020 |
|
|
2024
Q2 | $235K | Buy |
+3,519
| New | +$235K | ﹤0.01% | 2906 |
|
|
2019
Q3 | – | Sell |
-2,373
| Closed | -$227K | – | 2411 |
|
|
2019
Q2 | $227K | Sell |
2,373
-1,173
| -33% | -$112K | ﹤0.01% | 1923 |
|
|
2019
Q1 | $313K | Sell |
3,546
-31
| -0.9% | -$2.74K | ﹤0.01% | 1779 |
|
|
2018
Q4 | $297K | Buy |
3,577
+31
| +0.9% | +$2.57K | ﹤0.01% | 1679 |
|
|
2018
Q3 | $334K | Hold |
3,546
| – | – | ﹤0.01% | 1725 |
|
|
2018
Q2 | $391K | Hold |
3,546
| – | – | ﹤0.01% | 1552 |
|
|
2018
Q1 | $351K | Hold |
3,546
| – | – | ﹤0.01% | 1557 |
|
|
2017
Q4 | $289K | Buy |
+3,546
| New | +$289K | ﹤0.01% | 1682 |
|